Anti-viral pharmaceutical compositions

Details Anti-viral pharmaceutical compositions Anti-viral pharmaceutical compositions

2011-06-28

2011-06-28

Hartley, Michael G (Department: 1618)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

Reexamination Certificate

active

07968122

ABSTRACT:
The present invention provides antiviral compositions that comprise one or more of an ionic multivalent metal component, a cationic polymer, and a cationic surfactant. The present invention also provides methods for making and using such antiviral compositions.

REFERENCES:
patent: 3404987 (1968-10-01), Kooistra et al.
patent: 4465666 (1984-08-01), Lukas et al.
patent: 4503070 (1985-03-01), Eby, III
patent: 4548950 (1985-10-01), Baxendale et al.
patent: 4661354 (1987-04-01), Finnerty
patent: 4956385 (1990-09-01), Eby, III
patent: 5100879 (1992-03-01), Ueno et al.
patent: 5629011 (1997-05-01), Illum
patent: 5711938 (1998-01-01), Larm
patent: 5798391 (1998-08-01), Lagny et al.
patent: 6080783 (2000-06-01), Davidson et al.
patent: 6139864 (2000-10-01), Dürr et al.
patent: 6207653 (2001-03-01), Larm et al.
patent: 6231889 (2001-05-01), Richardson et al.
patent: 6284289 (2001-09-01), Van den Berghe
patent: 6321750 (2001-11-01), Kelly
patent: 6391318 (2002-05-01), Illum et al.
patent: 6423329 (2002-07-01), Sine et al.
patent: 6428814 (2002-08-01), Bosch et al.
patent: 6455061 (2002-09-01), Richardson et al.
patent: 6534065 (2003-03-01), Makin et al.
patent: 6570054 (2003-05-01), Gatto et al.
patent: 6632445 (2003-10-01), Richardson et al.
patent: 7163720 (2007-01-01), Dhaler et al.
patent: 2002/0022660 (2002-02-01), Jampani et al.
patent: 2002/0136768 (2002-09-01), Staats
patent: 2002/0151521 (2002-10-01), Burke et al.
patent: 2003/0133993 (2003-07-01), Hutcheson et al.
patent: 2003/0206958 (2003-11-01), Cattaneo et al.
patent: 2004/0033260 (2004-02-01), Rennie et al.
patent: 2004/0057996 (2004-03-01), Takada et al.
patent: 2004/0072733 (2004-04-01), Killam
patent: 2004/0102429 (2004-05-01), Modak et al.
patent: 1457797 (2003-11-01), None
patent: 0012115 (1980-06-01), None
patent: 0 692 253 (1996-01-01), None
patent: 0692253 (1996-01-01), None
patent: 508760 (1998-11-01), None
patent: WO 95/28158 (1995-10-01), None
patent: WO 96/41643 (1996-12-01), None
patent: WO 00/15192 (2000-03-01), None
patent: PCT/JP 01/11420 (2001-12-01), None
patent: WO 03/060003 (2003-07-01), None
patent: WO 2004/039379 (2004-05-01), None
patent: WO 2004/080210 (2004-09-01), None
Arnberg, N. et al., “Adenovirus Type 37 Binds to Cell Surface Sialic Acid Through a Charge-Dependent Interaction,”Virology, 302(1):33-43, Oct. 10, 2002.
Bossche, G. V., “Alteration of viral infectious behavior by surface active agents,”Microbiol. Res., 149(2):105-114, Jun. 1994.
Hughs, M.P. et al., Measuring the dielectric properties of herpes simplex virus type 1 virions with dielectrophoresis,Biochimica et Biophysica Acta, 1571(1):1-8, May 10, 2002.
In-Pharma Technologist.com, “West Pharma plans drug delivery exit,”,West Pharmaceutical Services of the U.S., Jan. 7, 2004, URL http://www.in-pharmatechnologist.com
ews/printNewsBis.asp?id=53243, download date Jun. 1, 2005.
Novick, S.G. et al., “How Does Zinc Modify the Common Cold? Clinical Observations and Implications Regarding Mechanisms of Action,”Medical Hypotheses., 46(3):295-302, Mar. 1996.
West Pharmaceutical Services, “Nasal Delivery,” URL http://www.westpharma.com/drug%20delivery
asal—delivery.asp, download date Sep. 14, 2004.
West Pharmaceutical Services, “Vaccine Delivery,” URL http://www.westpharma.com/drug%20delivery/vaccine—delivery.asp, download date Sep. 14, 2004.
Akihama, S. and Toyoshima, S., “Antiviral Effect of Zinc Complexes on Japanese B Encephalitis Virus,”Chemical&Pharmaceutical Bulletin, 10(12):1254-1261, Aug. 1962.
Chandy, T. and Sharma, C. P., “Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads,”Biomaterials, 17(1):61-66, 1996.
Geist, F. C. et al., “In Vitro Activity of Zinc Salts against Human Rhinoviruses,”Antimicrobial Agents and Chemotherapy, 31(4):622-624, Apr. 1987.
Rabea, E. I. et al., “Chitosan as Antimicrobial Agent: Applications and Mode of Action,”American Chemical Society, 4(6):1457-1465, Nov./Dec. 2003.
Varadinova, T. L. et al., “Mode of Action of Zn-Complexes on Herpes Simplex Virus Type 1 Infection in Vitro,”Journal of Chemometrics, 5(1):3-9, 1993.
Chandy et al., “Effect of liposome-albumin coatings on ferric ion retention and release from chitosan beads,”Biomaterials 17:61-66, 1996.
Rabea et al., “Chitosan as Antimicrobial Agent: Applications and Mode of Action,”Biomacromolecules 4(6), 1457-1465, Nov./Dec. 2003.
Yang et al., “Herpetic Simplex Keratitis and Trace Element Zinc,”Chinese Ophthalmic Research 8(4): 204-205, 1990.
Zai et al., “A Model of Hepadnavirus Infection and its Use in Anti-Infective Research,”Disease Surveillance 10:383-385, 2002. (Cited Reference D5 at pp. 5-6, Office Action dated Sep. 12, 2008.

Affiliated with

Also associated with

Rating

Anti-viral pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-viral pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-viral pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2711420